Literature DB >> 28894599

Occurrence and management of bioresorbable vascular scaffold failure in real-life studies.

Bernardo Cortese1,2, Mostafa Elwany1,3.   

Abstract

Bioresorbable vascular scaffold (BVS) has emerged as a new technology aiming at overcoming some drawbacks of the conventional metallic stent. In spite of the initial promising results, this technology stumbled upon numerous challenges, which were revealed in the real world studies. Thanks to real world trials and registries findings, our knowledge about the BVS has grown over time, thus we have understood on BVS behavior in various settings and formulated better implantation techniques. In this article, we will review the incidence of BVS failure in real world studies, its different etiologies and management strategies.

Entities:  

Keywords:  Bioresorbable vascular scaffold (BVS); scaffold failure

Year:  2017        PMID: 28894599      PMCID: PMC5583083          DOI: 10.21037/jtd.2017.06.82

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  22 in total

1.  From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?

Authors:  Patrick W Serruys; Hector M Garcia-Garcia; Yoshinobu Onuma
Journal:  Eur Heart J       Date:  2011-10-31       Impact factor: 29.983

2.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

3.  The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled.

Authors:  Alexandre Abizaid; J Ribamar Costa; Antonio L Bartorelli; Robert Whitbourn; Robert Jan van Geuns; Bernard Chevalier; Tejas Patel; Ashok Seth; Marrianne Stuteville; Cécile Dorange; Wai-Fung Cheong; Krishnankutty Sudhir; Patrick W Serruys
Journal:  EuroIntervention       Date:  2015-04       Impact factor: 6.534

4.  Comparative Characterization of Biomechanical Behavior and Healing Profile of a Novel Ultra-High-Molecular-Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.

Authors:  Yanping Cheng; Pawel Gasior; Masahiko Shibuya; Kamal Ramzipoor; Chang Lee; Edward A Estrada; Daniell Dokko; Jenn C McGregor; Gerard B Conditt; Greg L Kaluza; Juan F Granada
Journal:  Circ Cardiovasc Interv       Date:  2016-10       Impact factor: 6.546

5.  Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry.

Authors:  Robin P Kraak; Mariëlla E C J Hassell; Maik J Grundeken; Karel T Koch; Jose P S Henriques; Jan J Piek; Jan Baan; Marije M Vis; E Karin Arkenbout; Jan G P Tijssen; Robbert J de Winter; Joanna J Wykrzykowska
Journal:  EuroIntervention       Date:  2015-02       Impact factor: 6.534

6.  First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.

Authors:  Roberto Adriano Latini; Dario Buccheri; Bernardo Cortese
Journal:  Catheter Cardiovasc Interv       Date:  2016-09-21       Impact factor: 2.692

7.  Restenosis of Coronary Bioresorbable Vascular Scaffolds.

Authors:  Fernando Alfonso; Marcos García-Guimaraes
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2017-03-09

8.  First experience of drug-coated balloons for treatment of bioresorbable vascular scaffold restenosis.

Authors:  Mostafa Elwany; Roberto Adriano Latini; Gaetano Di Palma; Pedro Silva Orrego; Bernardo Cortese
Journal:  Cardiovasc Revasc Med       Date:  2017-03-25

Review 9.  Very Late Scaffold Thrombosis of Bioresorbable Vascular Scaffold: Systematic Review and a Meta-Analysis.

Authors:  Toshiaki Toyota; Takeshi Morimoto; Hiroki Shiomi; Yusuke Yoshikawa; Hidenori Yaku; Yugo Yamashita; Takeshi Kimura
Journal:  JACC Cardiovasc Interv       Date:  2017-01-09       Impact factor: 11.195

Review 10.  Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

Authors:  Salvatore Cassese; Robert A Byrne; Gjin Ndrepepa; Sebastian Kufner; Jens Wiebe; Janika Repp; Heribert Schunkert; Massimiliano Fusaro; Takeshi Kimura; Adnan Kastrati
Journal:  Lancet       Date:  2015-11-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.